Poor adherence to prescribed TB treatment is a common cause of treatment failure and relapse.29
Adherence is optimized when TB medications are delivered as part of a comprehensive, patient-centred program that promotes patient understanding and removes barriers to adherence, rather than a focus on adherence to pharmacologic therapy alone.1,37 Incentives and enablers can also help mitigate any social and economic marginalization a person may be experiencing. Early linkage with a social worker, along with early engagement with appropriate governmental and community organizations, is recommended when treating people from marginalized populations.
Examples of incentives and enablers that can be used include:1,37–40
-
peer counseling;
-
patient reminders and following up on missed appointments;
-
integration into primary or specialty care (eg, HIV care, dialysis, mental health services, methadone delivery);
-
financial supports, including stipends, personal products, coupons and gift cards;
-
social assistance for housing and to gain access to or funding of healthcare services;
-
assistance with transportation and childcare;
-
reminder systems for appointments;
-
field or home visits;
-
blister packing medications;
-
video directly observed therapy.
Good practice statements
-
The decision by a care provider to initiate treatment of TB disease implies a commitment to ensuring that a person with TB completes their TB therapy safely and with minimal interruption. This is best done by providing a comprehensive, patient-centred treatment program, which may include incentives and enablers.
-
People with TB disease should be provided all medications and services required to successfully complete TB therapy free of charge, regardless of their insurance coverage or residency status in Canada.
Switch To: Français